Intrinsiqs

Is Axsome Therapeutics, Inc. overvalued?

Axsome Therapeutics, Inc. (AXSM) — key valuation metrics and fundamentals.

No verdict
Price
$242.62
Fair value
Current P/E
Normal P/E
Market cap
$12.60B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares AXSM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.